Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial - Raygan, F; Ostadmohammadi, V; Bahmani, F; Reiter, R J; Asemi, Z (Clin Nutr, 2017)
pii: S0261-5614(17)31424-3.